Blood Sugar Regulation Semaglutide is designed to lower and stabilize blood glucose levels
Variables such as age, sex, race, comorbidities (eg, diabetes, obesity, chronic kidney disease, hypertension), and lifestyle factors used 1:1 propensity matching to reduce confounding
Over two years, the average change in weight loss was 15.2% in those who received Wegovy versus 2.6% in people who received a placebo
This is because research shows that SAP may help control acne by reducing acne-causing bacteria and slowing the oxidation of skin oils caused by UV exposure
Research is still limited, and effects can vary by dose and conditions
The FDA approved Tirzepatide in May 2022 for type 2 diabetics